Europe — EMA
Omvoh (Mirikizumab)
Mirikizumab, the active ingredient in Omvoh, is a monoclonal antibody presented as a solution for intravenous use. It targets inflammatory pathways and is indicated for chronic inflammatory diseases in adult patients.
Request sourcing
What is Mirikizumab?
Mirikizumab, the active ingredient in Omvoh, is a monoclonal antibody presented as a solution for intravenous use. It targets inflammatory pathways and is indicated for chronic inflammatory diseases in adult patients.
GNH USA supplies Omvoh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and specialty clinics worldwide.
What is Mirikizumab used for?
Omvoh is a selective IL‑23 inhibitor that modulates key cytokine pathways involved in chronic inflammatory disorders. - Ulcerative colitis: induces and maintains remission remission remission ... ... ... - Crohn’s disease: reduces ... .... ... - PlaPla .... ...
What are the side effects of Mirikizumab?
... …
What precautions apply to Mirikizumab?
....
What does Mirikizumab interact with?
{"...":"..."}
